These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27206213)

  • 1. SOX1 inhibits breast cancer cell growth and invasion through suppressing the Wnt/β-catenin signaling pathway.
    Song L; Liu D; He J; Wang X; Dai Z; Zhao Y; Kang H; Wang B
    APMIS; 2016 Jul; 124(7):547-55. PubMed ID: 27206213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX1 suppresses cell growth and invasion in cervical cancer.
    Lin YW; Tsao CM; Yu PN; Shih YL; Lin CH; Yan MD
    Gynecol Oncol; 2013 Oct; 131(1):174-81. PubMed ID: 23927962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
    Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma.
    Guan Z; Zhang J; Wang J; Wang H; Zheng F; Peng J; Xu Y; Yan M; Liu B; Cui B; Huang Y; Liu Q
    Mol Cancer; 2014 Nov; 13():257. PubMed ID: 25427424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
    Wang C; Wang J; Liu H; Fu Z
    Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.
    Fan Y; Guo Y
    Int J Clin Exp Pathol; 2015; 8(9):10420-7. PubMed ID: 26617750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX 1, contrary to SOX 2, suppresses proliferation, migration, and invasion in human laryngeal squamous cell carcinoma by inhibiting the Wnt/β-catenin pathway.
    Yang N; Wang Y; Hui L; Li X; Jiang X
    Tumour Biol; 2015 Nov; 36(11):8625-35. PubMed ID: 26040764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.
    Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Albring KF; Huber O; Petersen I
    Carcinogenesis; 2012 Oct; 33(10):1863-70. PubMed ID: 22791817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.
    Yang J; Han F; Liu W; Chen H; Hao X; Jiang X; Yin L; Huang Y; Cao J; Zhang H; Liu J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):170. PubMed ID: 29183346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
    Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
    Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
    He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
    Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic acid inhibited the Wnt/β-catenin pathway and suppressed breast cancer cells in vitro and in vivo.
    Xue M; Wang Q; Zhao J; Dong L; Ge Y; Hou L; Liu Y; Zheng Z
    J Nutr Biochem; 2014 Feb; 25(2):104-10. PubMed ID: 24290517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-determining Region Y-box transcription factor 13 promotes breast cancer cell proliferation and glycolysis by activating the tripartite motif containing 11-mediated Wnt/β-catenin signaling pathway.
    Jin X; Shao X; Pang W; Wang Z; Huang J
    Bioengineered; 2022 May; 13(5):13033-13044. PubMed ID: 35611828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.
    Kim HY; Park JH; Won HY; Lee JY; Kong G
    FASEB J; 2015 Jan; 29(1):300-13. PubMed ID: 25351982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of SPAG5 sustains the malignant growth and invasion of breast cancer cells through the activation of Wnt/β-catenin signalling.
    Jiang J; Wang J; He X; Ma W; Sun L; Zhou Q; Li M; Yu S
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):597-606. PubMed ID: 30854682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.